|
| 1 |
Persistence with Denosumab in Male Osteoporosis Patients: A Real-World, Non-Interventional Multicenter Study
Chaiho Jeong, Jeongmin Lee, Jinyoung Kim, Jeonghoon Ha, Kwanhoon Jo, Yejee Lim, Mee Kyoung Kim, Hyuk-Sang Kwon, Tae-Seo Sohn, Ki-Ho Song, Moo Il Kang, Ki-Hyun Baek
Endocrinol Metab.2023;38(2):260-268. Published online 2023 April 27
DOI: http://dx.doi.org/10.3803/EnM.2023.1663
|
|
| 2 |
A Case of Inferior Turbinate Osteonecrosis Due to Denosumab
Yongmin Cho, Dongha Kim, Jae-Min Shin, Il-Ho Park
|
|
| 3 |
Real-World Safety and Effectiveness of Denosumab in Patients with Osteoporosis: A Prospective, Observational Study in South Korea
Yumie Rhee, Dong-Gune Chang, Jeonghoon Ha, Sooa Kim, Yusun Lee, Euna Jo, Jung-Min Koh
|
|
| 4 |
Discontinuing Denosumab: Can It Be Done Safely? A Review of the Literature
Wei Lin Tay, Donovan Tay
Endocrinol Metab.2022;37(2):183-194. Published online 2022 April 14
DOI: http://dx.doi.org/10.3803/EnM.2021.1369
|
|
| 5 |
Comparison of Denosumab and Zoledronic Acid in Postmenopausal Women With Osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS)
Taewook Kang, Si Young Park, Soon Hyuck Lee, Jong Hoon Park, Seung Woo Suh
|
|
| 6 |
Review and Update of the Risk Factors and Prevention of Antiresorptive-Related Osteonecrosis of the Jaw
Ha Young Kim
Endocrinol Metab.2021;36(5):917-927. Published online 2021 October 21
DOI: http://dx.doi.org/10.3803/EnM.2021.1170
|
|
| 7 |
Long-Term Treatment of Postmenopausal Osteoporosis
Jacques P. Brown
Endocrinol Metab.2021;36(3):544-552. Published online 2021 June 22
DOI: http://dx.doi.org/10.3803/EnM.2021.301
|
|
| 8 |
Chondroblastoma’s Lung Metastases Treated with Denosumab in Pediatric Patient
Marco Focaccia, Marco Gambarotti, Rossella Hakim, Anna Paioli, Marilena Cesari, Benedetta Spazzoli, Paolo Spinnato, Davide Donati, Michele Rocca, Alessandra Longhi
Cancer Res Treat.2021;53(1):279-282. Published online 2020 August 6
DOI: http://dx.doi.org/10.4143/crt.2020.384
|
|
| 9 |
Effect of Osteoporosis Medication on Fracture Healing: An Evidence Based Review
Young Ho Shin, Won Chul Shin, Ji Wan Kim
J Bone Metab.2020;27(1):15-26. Published online 2020 February 29
DOI: http://dx.doi.org/10.11005/jbm.2020.27.1.15
|
|
| 10 |
Dental care for patients taking antiresorptive drugs: a literature review
Minju Song
|
|
| 11 |
Evaluation of Local Recurrence in Giant-Cell Tumor of Bone Treated by Neoadjuvant Denosumab
Pramod Shekarappa Chinder, Suraj Hindiskere, Srinath Doddarangappa, Utkarsh Pal
|
|
| 12 |
Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis
So Young Park, Hyun Sik Gong, Kyoung Min Kim, Dam Kim, Ha Young Kim, Chan Hong Jeon, Ji Hyeon Ju, Shin-Seok Lee, Dong-Ah Park, Yoon-Kyoung Sung, Sang Wan Kim
J Bone Metab.2018;25(4):195-211. Published online 2018 November 30
DOI: http://dx.doi.org/10.11005/jbm.2018.25.4.195
|
|
| 13 |
Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis
So Young Park, Hyun Sik Gong, Kyoung Min Kim, Dam Kim, Hayoung Kim, Chan Hong Jeon, Ji Hyeon Ju, Shin-Seok Lee, Dong Ah Park, Yoon-Kyoung Sung, Sang Wan Kim
J Rheum Dis.2018;25(4):263-295. Published online 2018 October 1
DOI: http://dx.doi.org/10.4078/jrd.2018.25.4.263
|
|
| 14 |
Can denosumab be a substitute, competitor, or complement to bisphosphonates?
Su Young Kim, Hwoe Gyeong Ok, Christof Birkenmaier, Kyung Hoon Kim
|
|
| 15 |
Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension
Jung-Min Koh, Dong Jin Chung, Yoon-Sok Chung, Moo-Il Kang, In-Ju Kim, Yong-Ki Min, Han-Jin Oh, Il Hyung Park, Yil-Seob Lee, Barbara Kravitz, Brian Waterhouse, Antonio Nino, Lorraine A. Fitzpatrick
|
|
| 16 |
Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
Yong-Ki Min
|
|
